Men are diagnosed with obesity, referred and treated less often than women, Medscape finds, and some strategies to narrow that gap are starting to appear.
Recap by typeshit. Full story at Medscape.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
Presented at Sleep Europe 2026, both trials found retatrutide lowered the apnea-hypopnea index more than placebo, including in people with type 2 diabetes.
Endpoints News
Endpoints reports Eli Lilly is building a case for its triple agonist beyond obesity, where a launch is expected next year, with sleep apnea next in line.
Observational data link GLP-1 drugs to fewer cases of some cancers, but trials have yet to show they prevent cancer or help survival after a diagnosis.
His family says his BMI fell from 36 to 22.8 over two years on Wegovy, and he has since joined a cheer team. His doctor says the drug isn't right for every child.
The analysis points to CagriSema filings, a DKK 15b buyback and Wegovy pill capacity, while flagging margin pressure and flat 2026 guidance as risks.
Loading…